Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator

NCT02526290 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes
Keratoconjunctivitis Sicca

Interventions

DEVICE: Intranasal Lacrimal Neurostimulator (Oculeve)

Sponsor

Oculeve, Inc.